Latest:
The Good Fight
- About Us
- Advertise / Support
- Editorial Board
- Contact Us
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2025 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Contributors
Daniel Jernazian
Daniel Jernazian is a two-time cancer survivor, surviving Hodgkin’s lymphoma in 2003 and beating thyroid cancer in 2021.
Latest:
A Cancer Survivor Calls Beating the Disease a ‘World Championship’
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Dr. Douglas B. Johnson
Dr. Douglas B. Johnson is a physician-scientist and professor of medicine in the Division of Hematology/Oncology at Vanderbilt University Medical Center, where he leads the melanoma clinical research program, located in Nashville, Tennessee.
Latest:
Expert Shares Key Insights During Melanoma Awareness Month
For Melanoma Awareness Month, Dr. Douglas Johnson explains how stage and features of the disease can guide treatment decisions after diagnosis.
Kathryn Johnson, DNP
Kathryn Johnson, DNP, is a clinical program manager at The Derald H. Ruttenberg Treatment Center at The Tisch Cancer Institute, part of The Mount Sinai Hospital in New York City.
Latest:
Why Relationships are Key When Caring For Patients With MPNs
Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence.
Dr. Robert Jones
Dr. Robert Jones is a professor of Clinical Cancer Research at the University of Glasgow School of Cancer Sciences, in Scotland.
Latest:
Bavencio Has Efficacy in The Real-World Treatment of Urothelial Cancer
Following treatment with Bavencio, patients with urothelial cancer lived for 17 months and their cancer remained stable for nine months.
Dr. Andreas M. Kaiser
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Latest:
Colostomies and Colon Cancer, a Lifesaving Choice, Not a Last Resort
Dr. Andreas M. Kaiser explains how a colostomy may preserve a patient’s health and help to avoid colorectal cancer complications.
Virginia Kaklamani, MD, DSc
Latest:
Real-World Experience: The Efficacy and Tolerability of Oral Elacestrant for Patients with ESR1 Mutations
Panelists discuss how real-world studies have shown improved outcomes with elacestrant compared with the original EMERALD trial data, demonstrating that proper patient selection leads to better treatment responses.
Dr. Suneel Kamath
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.
Latest:
Breaking Down The Importance of Targeted Therapies in Colorectal Cancer Care
Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.